Background: Hypertension and obesity are highly interrelated diseases, being critical components of the metabolic syndrome. Despite the growing prevalence of this syndrome in the world population, efficient therapies are still missing. Thus, identification of novel targets and therapies are warranted. An enhanced activity of the hypothalamic renin-angiotensin system (RAS), including the recently discovered prorenin (PR) and its receptor (PRR), has been implicated as a common mechanism underlying aberrant sympatho-humoral activation that contributes to both metabolic and cardiovascular dysregulation in the metabolic syndrome. Still, the identification of precise neuronal targets, cellular mechanisms and signaling pathways underlying PR/PRR actions in cardiovascular-and metabolic related hypothalamic nuclei remain unknown. Methods and results: Using a multidisciplinary approach including patch-clamp electrophysiology, live calcium imaging and immunohistochemistry, we aimed to elucidate cellular mechanisms underlying PR/PRR actions within the hypothalamic supraoptic (SON) and paraventricular nucleus (PVN), key brain areas previously involved in cardiometabolic regulation. We show for the first time that PRR is expressed in magnocellular neurosecretory cells (MNCs), and to a lesser extent, in presympathetic PVN neurons (PVN PS ). Moreover, we show that while PRR activation efficiently stimulates the firing activity of both MNCs and PVN PS neurons, these effects involved AngII-independent and AngII-dependent mechanisms, respectively. In both cases however, PR excitatory effects involved an increase in intracellular Ca 2þ levels and a Ca 2þ -dependent inhibition of a voltage-gated K þ current.
INTRODUCTION
It is well-established that the brain renin-angiotensin system plays a critical role in hydromineral and cardiovascular regulation, and that an elevated central RAS contributes to cardiovascular diseases, particularly neurogenic hypertension [1e3] . In addition to its canonical role in cardiovascular function, the RAS has recently emerged as a critical mediator of the hypothalamic control of body weight and metabolic functions [4, 5] . An increase RAS activity, resulting in elevated levels of AngII and AngII type 1a receptors (AT1a) in the brain, has been reported both in obese humans and animal models [4,6e8] . Moreover, increasing central RAS activity, either genetically or pharmacologically, decreased body weight by inhibiting food intake and elevating energy expenditure [9e12] . Hypertension and obesity are highly interrelated diseases, being critical components of the metabolic syndrome. Diet-induced obesity in humans and rodents is associated with increased prevalence of hypertension [13e15] , and several studies implicate an altered central RAS in obesity-induced hypertension [16e18] . Furthermore, neurogenic forms of hypertension caused by an elevated brain RAS activity display several metabolic disturbances [5] . Importantly, a mechanistic interaction between energy balance-related signals (e.g., leptin) and the central RAS in the functional regulation of sympathetic nerve activity has been reported both in health and disease conditions [19, 20] . Finally, AngII is a pro-inflammatory factor [21] , and inflammation within the hypothalamus has been associated both with hypertension and obesity [16,22e25] . Collectively, these results suggest that an altered brain RAS activity could be a common mechanism underlying both cardiovascular and energy balance changes in the metabolic syndrome. Neurons within the paraventricular nucleus of the hypothalamus (PVN) are well suited to mediate the effects of the central RAS on cardiovascular and metabolic regulation. Parvocellular presympathetic neurons, via projections to the brainstem and spinal cord [26] , influence food intake, energy expenditure and blood pressure [27e29] . Magnocellular neurosecretory cells (MNCs) that project to the posterior pituitary (also present in the supraoptic nucleus, SON) [26] , release oxytocin and vasopressin onto the circulation. These hormones, in addition to their well-established effects on fluid and electrolyte homeostasis, also influence metabolic function and food intake [30e34] . All the components of the RAS needed for the local generation of angiotensin peptides are present within the SON and PVN [35] , including two of the most novel players, namely prorenin (PR) and its receptor (PRR) [36e38] . Binding of PR to PRR stimulates the catalytic activity of the receptor, converting angiotensinogen (AGT) to angiotensin I and II [36, 38] . In addition, interaction of PR with PRR initiates intracellular signaling pathways, including mitogen-activated protein kinases (MAPK) and extracellular signal-regulated kinases 1 and 2 (ERK1/2) [39e41]. Thus, the PR/PRR complex can mediate both AngIIdependent and independent effects. An altered RAS activity within the SON/PVN leads to aberrant sympatho-humoral outflows characteristic of both hypertension and the metabolic syndrome. For example, an increased PRR expression was reported in the SON and PVN in hypertensive mice and rats [42, 43] , while brain-targeted PRR knockdown decreased blood pressure, sympathetic tone and plasma VP levels in these rodents [38, 42] . Importantly, both AngII-dependent [44] and independent [43] , mechanisms where shown to mediate effects of PRR in these nuclei. Furthermore, deletion of AT1a receptors in the PVN of high-fat diet obese mice increased food intake, decreased energy expenditure and decreased systolic blood pressure [45] , supporting a key role for AT1a receptors in the PVN in the regulation of cardiometabolic function during obesity. While PR and PRR in adipose tissue have been recently implicated in the development of obesity and obesity-induced hypertension [46, 47] , their contribution to hypothalamic control metabolic function, both in health and disease is much less understood. Despite all this evidence, the identification of precise neuronal targets, cellular mechanisms and signaling pathways underlying PR-mediated sympatho-humoral activation within cardiovascular and metabolic related brain centers remain unknown. This fundamental mechanistic information regarding central PR/PRR actions is critical before this signaling unit can become an efficient and novel therapeutic target for the treatment of cardiometabolic disorders. The degree of sympathetic and hormonal outputs from the SON/PVN is dependent on neuronal activity in these nuclei, which is in turn determined by the combined actions of intrinsic (ion channels) and extrinsic (neurotransmitters) factors. Thus, it is reasonably to speculate that PR/PRR actions within the SON/PVN to stimulate sympathohumoral activation are mediated by increasing membrane excitability and evoking firing activity in these neuronal populations. Surprisingly however, there have been no studies in the literature thus far that investigated this, nor explored the precise underlying cellular mechanisms by which PR mediates neurohumoral activation within the brain. Here, we used a multidisciplinary experimental approach including patch-clamp electrophysiology, live confocal calcium imaging and immunohistochemistry to elucidate cellular mechanisms underlying PR/PRR actions within the SON/PVN.
METHODS

Ethical approval
All procedures were performed in agreement with guidelines of the Augusta University Institutional Animal Care and Use Committee and were approved by the committee. Male heterozygous transgenic eGFP-VP Wistar rats (4e6 weeks old) were used [48] . Rats were housed in rooms with constant temperature of 22e24 C and under a controlled light/dark cycle (12 h: 12 h), with normal rat chow and drinking water ad libitum.
Retrograde tracing
To identify presympathetic PVN neurons for patch-clamp or immunohistochemistry, rhodamine-labeled microspheres (Lumaflor) or cholera toxin B (CTB; 1%; List Biological Laboratories, 400 nl), respectively, were microinjected into the RVLM, a major brainstem sympathetic center. Coordinates used starting from bregma: 12 mm caudal along the lamina, 2 mm medial lateral, and 8 mm ventral as previously described [49] . The location of the tracer was verified histologically. Animals were used for electrophysiological or immunohistochemical studies 3e4 days after surgery.
2.3. Slice preparation Hypothalamic brain slices were prepared according to methods previously described [50, 51] . Briefly, rats were anesthetized with pentobarbital (50 mg/kg ip); brains dissected out and hypothalamic coronal slices (240 mm) containing the SON/PVN were cut in an oxygenated ice-cold artificial cerebrospinal fluid (aCSF), containing in mM: 119 NaCl, 2. 
Confocal calcium imaging
Neurons were loaded through the patch pipette with Fluo-5F pentapotassium salt (50 mM; Invitrogen), as previously described [53] . Imaging was conducted using the Andor Technology Revolution system (iXON EMCCD camera with the Yokogawa CSU 10, confocal scanning unit). Fluorescence images were acquired at a rate of 4 Hz, using an excitation light of 488 nm and emitted light at >495 nm (Fluo-5F). The fractional fluorescence (F/F0) was determined by dividing the fluorescence intensity (F) within a region of interest by a baseline fluorescence value (F0) determined from 50 images before PR application [54] . Data were analyzed using ImageJ software. . Incubation in primary antibodies was followed by specific fluorescently labeled secondary antibodies (1:250; Jackson ImmunoResearch Laboratories) for 4 h. The specificity of the anti-PRR antibody generated in the laboratory of Dr. Feng was validated in a neuron-specific PRR knockout mouse [44] , as well as in cell lines using PRR-shRNA [42] . Slices were then rinsed and visualized using a Zeiss LSM 510 Confocal Microscope System (Carl Zeiss, Oberkochen, Germany) [55] . Twenty consecutive optical focal planes (2 mm interval)
were acquired from sections containing the middle level of the lateral magnocellular subnucleus of the PVN and the middle part of the SON (Bregma ¼ À1.40 to À1.80) and a projection image was generated as a single section. OT and VP immunoreactive MNCs from the SON and the PVN subnuclei, as well as retrogradely-labeled PVN PS neurons were individually traced within their respective acquisition channels using a freehand tool within ImageJ software (1.47v, National Institutes of Health, USA). The channel was then switched to the one containing the PRR immunoreactivity, and the mean PRR immunofluorescence intensity within the traced cell was obtained and expressed in arbitrary units ranging from 0 (absolute black) to 4095 (absolute white). Background intensity was calculated from adjacent areas and was subtracted from all images. A mean value of all sampled neurons was obtained and used for comparisons.
Statistical analysis
All values are expressed as means AE SE. Student's paired t tests were used to compare the effects of drug treatment. One-way ANOVA tests with Bonferroni post hoc tests were used as needed. Differences were considered significant at p < 0.05 and n refers to the number of cells.
All statistical analyses were conducted using GraphPad Prism (GraphPad Software, San Diego, CA).
RESULTS
Prorenin stimulates firing activity of MNCs and PVN PS neurons
Whole-cell patch-clamp recordings were obtained from identified MNCs and presympathetic PVN neurons (PVN PS ), and measurements of changes in firing rate in response to PR were obtained. As shown in Figure 1 , focal application of PR (2. To determine whether the increased firing activity triggered by PR involved an underlying membrane depolarization, PR was applied to a subset of MNCs and PVN PS neurons that were hyperpolarized to w À10 mV from spike threshold, so that measurements of Vm could be obtained in the absence of action potentials. We found that PR application caused a significant membrane depolarization in both groups of neurons: MNCs: þ1.5 AE 0.2 mV, p < 0.0001; n ¼ 8; PVN PS : þ2.7 AE 0.8 mV p ¼ 0.03; n ¼ 5.
Prorenin excitatory effects involve different signaling mechanisms in MNCs and PVN PS neurons
To determine whether PR excitatory effects on SON and PVN neurons (a) required activation of the PRR, and (b) if they were AngII-dependent, we repeated experiments in the presence of a selective PRR antagonist (PRO20), or in the presence of the AT1 receptor blocker losartan. Given that PR effects did not wash-out within our recording period (see above), PR effects in these set of experiments were tested directly in the presence of either blocker. As shown in Figure 2 , PR-evoked increase in firing discharge in MNCs was blocked by bath application of a PRR antagonist (PRO20; 250 nM; before PR: 1.1 AE 0. Figure 2B ). Moreover, while a tendency for an excitatory effect was still observed in 5/6 neurons in the presence of PRO20, this did not reach statistical significance (before PR: 1.0 AE 0.2 Hz vs. after PR: 1.7 AE 0.4 Hz; p ¼ 0.09; n ¼ 6). These results suggest that while PR actions are primarily PRR-mediated and AngII-independent in MCNs, they are predominantly AngII-dependent in PVN PS neurons. Interestingly, regardless of the underlying mechanism involved, when PR excitatory effects were blocked in both neuronal types, a tendency for a masked inhibitory effect was unveiled. This phenomenon however was not further investigated in the present work. Generation of angiotensin peptides by PR/PRR requires the availability of the substrate angiotensinogen (AGT). Thus, to assess whether diminished availability of AGT could be a factor contributing to the lack of an AngII-mediated PR effect in MNCs, AGT (1 mg/ml) was added to the bathing solution when recording from these neurons. PR still triggered an increase in firing discharge in MNCs in the presence of high AGT levels (AGT 1.5 AE 0.3 Hz vs. AGT PR 3.1 AE 0.5 Hz; p ¼ 0.03; Figure 3, asterisks) . In cases where dendritic processes were sufficiently filled with the Ca 2þ -sensitive dye, we also observed an increase in dendritic [Ca 2þ ]i following PR application (see Figure 3A,B) . Taken together, our simultaneous Ca 2þ imaging/electrophysiology experiments suggest that the PR-induced increase in [Ca 2þ ]i could be an underlying mechanism contributing to the PR excitatory effect in MNCs and PVN PS neurons. To further confirm this, we assessed whether intracellular Ca 2þ chelation prevented PR excitatory effects. As shown in Figure 3D , PR-evoked increase in firing discharge was abolished when recorded neurons were dialyzed with the Ca 2þ chelator BAPTA (10 mM (Figure 4) . Action potentials were blocked by dialyzing neurons with QX314 (5 mM) in the patch pipette. Under these conditions, the ramps evoked predominantly voltage-gated outward currents ( Figure 4A ). PR application resulted in a significant decrease in the peak magnitude of the elicited outward currents in both MNCs (before PR 2657.8 AE 447.9 pA vs. after PR 2153.9 AE 365.3 pA; p ¼ 0.004; n ¼ 18, 4 of which where eGFP-VP neurons) and PVN PS neurons (before PR 3370.5 AE 796.7 pA vs. after PR 3231.0 AE 769.5 pA; p ¼ 0.02; n ¼ 12). The PR-sensitive current was isolated by digital subtraction of the evoked current before and after PR application (see insets in Figure 4 ), resulting in a net inward current. The PR-sensitive inward current in MNCs and PVN PS neurons activated at a Vm of À11.2 mV and À10.4 mV respectively, and had a mean peak amplitude of wÀ500 pA and wÀ110 pA (see Figure 4) , and a mean peak current density amplitude of 23.1 pA/pF and 2.8 pA/pF, respectively. Dialyzing neurons with a Cs þ -based internal solution, a broad spectrum Figure 4C ,D). In both cases, as shown in Figure 4 , a small PR-sensitive outward current was unveiled in the presence of BAPTA. Figure 5F ). Moreover, a stronger PRR immunoreactivity was observed in MNCs of the SON when compared to both neuronal types in the PVN (n ¼ 153; Figure 5 : Prorenin receptor (PRR) immunoreactivity in identified MNCs and PVN PS neurons in the SON and PVN. A, PRR immunoreactivity in the PVN (green, antibody generated in Dr. Feng's laboratory, A1), in which oxytocin (OT) MNCs (red) and PVN PS neurons (blue) were identified (A2). In A3, images in A1 and A2 were superimposed, and the areas contained within the white squares are reimaged at higher magnification and displayed in DeE. B, PRR immunoreactivity in the PVN (green, Abcam antibody, B1), in which vasopressin (VP) MNCs (red) and PVN PS neurons (blue) were identified (B2). In B3, images in B1 and B2 were superimposed. C, PRR immunoreactivity in the SON (green, antibody generated in Dr. Feng's laboratory, C1), in which both OT and VP neurons were identified (red, C2). In C3, images in C1 and C2 were superimposed. Figure 5F ). PRR immunoreactivity was not limited to MNCs and PVN PS neuronal populations, given that strong PRR staining was also observed in nonlabeled neurons throughout the PVN.
DISCUSSION
Despite the growing evidence highlighting the importance of the RAS in general, and PRR (one of the newer members of the RAS) in particular, in cardiometabolic control in obesity and hypertension [4, 5, 7, 43, 44, 46, 57] , the precise cellular targets and mechanisms underlying central PR/PRR signaling mechanisms remain largely unknown. Thus, the objective of this study was to investigate precise cellular mechanisms by which PR/PRR influence the activity of neurosecretory and presympathetic neurons within the hypothalamic SON and PVN, critical areas implicated in sympatho-humoral regulation by the central RAS. To this end, we used a multidisciplinary approach combining patch-clamp electrophysiology, live confocal imaging and immunohistochemistry. The present study reports several novel findings: 1) PR stimulated firing activity of both neurosecretory and presympathetic PVN neurons; 2) PR effects on both cell types involved binding to PRR (effects were blocked by PRO20). However, while effects on presympathetic neurons were AngII-dependent (blocked by losartan), stimulation of neurosecretory activity was AngII-independent; 3) PR/PRR excitatory effects were Ca 2þ -dependent, and involved inhibition of a Ca 2þ -sensitive outward K þ current; 4) We found PRR receptor expression both in VP and OT MNCs, and to a lesser degree, in presympathetic PVN neurons.
4.1. PR effects on PVN neuronal activity are cell-type dependent and involve AngII-dependent and -independent pathways It is now well established that binding of PR to PRR not only mediates formation of AngII via enzymatic conversion of AGT, but it also can lead to activation of a variety of intracellular signaling cascades, including, activation of the mitogen-activated protein kinases p38, ERK 1/2 and downstream targets, such as NADPH oxidase and NFKB [57] among others. Importantly, both AngII-dependent and independent PRR signaling pathways have been linked to the pathogenesis of neurogenic hypertension [37,42e44] . Still, whether these alternative PR/ PRR mediated pathways target distinct neuronal substrates and are in turn implicated in mediating particular components of the complex cardiovascular effects reported, including neuro-hormonal release and sympathoexcitation, is still incompletely understood. Our electrophysiological studies, showing for the first time that PR increased the firing activity of both MNCs and presympathetic PVN neurons, support these neuronal populations as key neuronal substrates mediating central actions of PR/PRR. Using a transgenic rat expressing eGFP driven by the VP promoter [48] , we were able to determine that PR/PRR stimulated the firing activity of both VP (eGFPlabeled) and OT neurons (eGFP-negative), the only two neuronal populations present in the SON [26, 48] . The fact that PRR affects both OT and VP neurosecretory neurons is also supported by our immunohistochemical studies showing expression of PRR in both neuronal populations. We acknowledge however that PRR staining was not limited to these neuronal populations, and that other PVN neurons involved in cardiometabolic control, such as CRH neurons, could also express PRR. Thus, future studies will be needed to obtain a complete characterization of PRR distribution in the PVN. Given their wide-ranging influence on fluid/electrolyte/energy balance, body weight, and sympathetic outflow to both cardiovascular-and metabolic-related targets, these three key hypothalamic neuronal populations (neurosecretory OT and VP and presympathetic neurons) play critical roles in cardiovascular and energy balance, and have been implicated in cardiometabolic dysregulation in hypertension and obesity. Taken together, our studies suggest that by modulating their firing activity, PR/PRR constitute critical players within the central RAS to affect cardiometabolic control by the PVN. Interestingly, PR effects on both MNCs and presympathetic PVN neurons were largely blunted by PRO20, a PRR antagonist that blocks both AngII formation and AngII-independent signaling [52] . Conversely, the AT 1 R blocker losartan was effective in blocking PR effects only in presympathetic neurons. Together, these results indicate that PR/PRR effects on MNCs and presympathetic PVN neurons involve AngIIindependent and dependent pathways, respectively. The fact that PR effects on two neuronal populations that are anatomically interrelated involved such disparate mechanisms is somewhat unexpected. This could be due, at least in part, to a differential expression of PRR and AT 1 Rs between these SON/PVN neuronal types. Previous studies showed that PRR is highly expressed in the SON and PVN, primarily in neurons [37, 38] , and that its expression is enhanced during hypertension [38, 42, 44] . However, the distribution of PRR within specific neuronal phenotypes in these regions has not been systematically explored. Our studies support the expression of PRR in neurosecretory VP and OT neurons, and to a lesser degree in presympathetic neurons, indicating that PR can directly act on these distinct neuronal populations. A caveat however, is that while we focally applied PR to these neurons, we cannot completely rule out the possibility that PR may have leaked out in the extracellular space to activate PRRs in other cell populations, such as microglia [58] , which may in turn contribute as intermediary cells to the neuronal effects herein described. We did not attempt to assess AT 1 R immunoreactivity in this study, given recent reports that questioned the specificity and validity of commercially available AT 1 R antibodies [59] . Thus, further studies using alternative experimental approaches will be needed to determine whether a differential expression of AT 1 Rs between MNCs and presympathetic neurons contribute to the AngII-independent and dependent mechanisms described in this study. It is worth mentioning that we found a higher PRR immunoreactivity in VP neurons of the SON compared to those in the PVN, a result that is in line with the stronger PRR effect we reported on the firing activity of SON, compared to MNCs in the PVN. Another caveat is that endogenous AGT levels, necessary for the formation of AngII by PRR, could be altered in the slice preparation. The fact that we were able to evoke an AngII/AT 1 R-mediated effect following PR application in PVN PS neurons would argue against lack of endogenous AGT in our preparation. Still, to rule out that the absence of an AngII-dependent response in MNCs was not due to diminished availability of AGT to this particular neuronal population, we repeated experiments in the presence of exogenously applied AGT. We found that PR effects on MNCs in this condition still persisted, and were unaffected by losartan, further supporting that PR/PRR in MNCs involve an AngII-independent mechanism. Our results showing that PR/PRR effects on presympathetic PVN neurons were AngII-dependent may seem in apparent conflict with a recent study showing that administration of human prorenin within the PVN elicited an AngII-independent increase in splanchnic, but not renal, sympathetic activity [37] . However, it is important to note that the PVN contains different subpopulations of presympathetic neurons that innervate distinct targets (i.e., RVLM, NTS, spinal cord). Thus, it is possible that PR regulation of sympathetic outflow to selective targets involves distinct subpopulations of PVN presympathetic neurons, which could in turn be differentially modulated by PR.
The concentration of PR used in this study was within the same range (nM) and even lower than those previously reported [37, 52, 57] . Importantly, the time course of the effect we observed was similar to those previously reported, with an onset after a few minutes of PR application [37, 43] . Moreover, Huber et al. recently reported that a single PR injection within the PVN resulted in a sympathoexcitatory response that remained elevated through the 110 min experimental period [37] . Thus, our results showing an irreversible effect of PR on SON/PVN firing activity, at least within the time period of our recordings, are in agreement with these in vivo studies. preceded the onset of firing. Given the slow kinetics of the Ca 2þ rise, we initially hypothesized that this increase in Ca 2þ was due to the slow Ca 2þ release from the ER, a major source of Ca 2þ in the SON and PVN [56] . However, we found that depleting the ER Ca 2þ stores with thapsigargin did not prevented PR effects. We also found that the PR effects persisted in a 0 Ca 2þ media, indicating that a slow-acting extracellular Ca 2þ source (e.g., a membrane transporter) or Ca 2þ channels were also not involved. Thus, it is likely that an alternative intracellular store, such as mitochondria, may serve as a source for the PR-mediated increase in intracellular Ca 2þ . We also found that PR inhibited a voltage-gated outward K þ current, and that chelation of intracellular Ca 2þ with BAPTA prevented both the inhibition of these outward inhibitory K þ current, as well as the PRevoked increase in firing discharge. These results together support the notion that PR/PRR excitatory effects on MNCs and presympathetic neurons involved a slow rise in intracellular Ca 2þ levels followed by inhibition of a voltage-gated K þ current, in a Ca 2þ -dependent fashion. Several Ca 2þ -dependent K þ channels are expressed in SON/PVN neurons, which efficiently regulate membrane excitability and firing discharge, including the large conductance BK, and the small conductance SK channels [60e63]. These K þ channels however, are activated by an increase in intracellular Ca 2þ . Thus, our studies showing that the PR-mediated increase in Ca 2þ resulted in inhibition of a K þ current argues against the involvement of BK and/or SK channels.
A Ca 2þ -dependent suppression of a voltage-gated K þ current (I DAP ) was previously demonstrated in MNCs [64] . Inhibition of this K þ current following a rise in intracellular Ca 2þ was shown to underlie a depolarizing after potential (DAP) and to evoke firing activity in MNCs. Another potential target mediating PR/PRR effects in SON/PVN neurons is the M-current (KCNQ2/3), a non-inactivating voltage-gated K þ current that is also suppressed by increases in intracellular Ca 2þ [65, 66] , and was shown to be present in MNCs [67] . Undoubtedly, further studies identifying the precise molecular identity of the K þ channel underlying PR/PRR actions, as well as the source of Ca 2þ leading to its inhibition, are warranted. In summary, we provide here novel evidence that indicates that PR stimulates hypothalamic MNCs and presympathetic PVN neuronal activity via distinct, AngII-independent and dependent mechanisms, respectively, and that these actions involve suppression of a voltagegated K þ channel in a Ca 2þ -dependent manner. Elucidating the basic cellular targets and mechanisms by which PR/PRR regulates neuronal activity within the hypothalamus is fundamental information required to obtain a more comprehensive understanding of how the central RAS influences sympatho-humoral regulation of cardiovascular and metabolic functions, both in health and disease states.
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